Search clinical trials for: Comparator: Placebo (unspecified)

Total 54652 results

Queen Mary University of London

Completed

Preventing Preterm Birth With Probiotics (PrePro)

Preterm Birth

United Kingdom
The Center for Clinical and Cosmetic Research
BirchBioMed Inc.

Completed

"A Clinical Study Investigating the Effectiveness of OTC Scar-management Modalities"

Cicatrix | Scar | Keloid | Hypertrophic Scar

United States
3M

Completed

A Clinical Study to Evaluate Effects of an Oral Rinse on Plaque and Gingivitis

Plaque

United States
University of New Mexico
National Institutes of Health (NIH); National Institute of General Medical... and other collaborators

Recruiting

Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia. (AphasiatDCS)

Stroke | Aphasia

United States
Merck Sharp & Dohme LLC

Completed

The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)

Hypertension
Merck Sharp & Dohme LLC

Completed

The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)

Dyslipidemia
Sucampo Pharma Americas, LLC

Terminated

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

Oral Mucositis

United States
Leiden University Medical Center

Completed

Fludrocortisone and Information Processing in Healthy Volunteers

Depression

Netherlands
Universidade de Passo Fundo

Completed

Spirulina Platensis for PPI Withdrawal (SpAReDPPI)

Dyspepsia | Gastro Esophageal Reflux Disease | Rebound Acid Hypersecretion
Aclaris Therapeutics, Inc.

Completed

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

Alopecia

United States
Cardenal Herrera University

Completed

Superficial Dry Needling Versus Deep Dry Needling on the Upper Trapezius

Neck Pain

Spain
Merck Sharp & Dohme LLC

Withdrawn

Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)

Chronic Genotype 1 Hepatitis C Virus Infection
Pfizer

Completed

Relative Bioavailability With PF-05089771 Capsule Versus Oral Dispersion

Healthy

Belgium
United States Naval Medical Center, San Diego

Terminated

Low -vs- High-Frequency Repetitive TMS of the Right Dorsolateral Prefrontal Cortex in PTSD

PTSD - Post Traumatic Stress Disorder
Zai Lab (Shanghai) Co., Ltd.

Active, not recruiting

A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer

Ovarian Cancer

China
Hvidovre University Hospital

Unknown

CDI Synbiotic Study

Clostridium Difficile Infection

Denmark
Ferring Pharmaceuticals

Completed

Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions (BASIC)

Infertility

Belgium, Spain, Australia, Canada, Czech Republic, Poland
Merck Sharp & Dohme LLC

Completed

V260 Registration Study (V260-013)(COMPLETED)

Rotavirus
AbbVie

Withdrawn

Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World Setting

Psoriasis
Universidad de Granada

Not yet recruiting

Ultrasound Patellar Tendon Assessment

Ultrasonography | Patellofemoral Pain

Spain
Rabin Medical Center

Completed

Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys

Low Weight | Short Stature | Growth Problem

Israel
Allergy Therapeutics
SynteractHCR; Metronomia Clinical Research GMBH

Completed

A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL (G104)

Seasonal Allergic Rhinitis

United States
Medical University of South Carolina
Invado Pharmaceuticals LLC

Completed

NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy

Xerostomia

United States
Humanigen, Inc.

Completed

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment (KB001-A)

Cystic Fibrosis

United States, Australia, Israel, New Zealand
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

Grass Pollen Allergy

Germany
PanGenetics UK Limited

Terminated

Single Dose PG102 in Patients With Active Psoriatic Arthritis

Arthritis, Psoriatic

Serbia
Anesiva, Inc.

Completed

Safety and Efficacy Study of 4975 in Patients Undergoing Total Knee Replacement

Total Knee Arthroplasty (Replacement)

United States
Solvay Pharmaceuticals

Completed

Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 Years

Healthy
Centre Hospitalier Universitaire de Nice

Recruiting

Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1 (REINFORCE)

Facioscapulohumeral Muscular Dystrophy 1

France, Canada
Capital Medical University
Beijing Friendship Hospital; China-Japan Friendship Hospital

Recruiting

Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease

Alzheimer Disease

China
Hospital Clinic of Barcelona

Recruiting

Effectiveness of a Smoking Cessation Intervention in a Mental Health Day Hospital (ESCIM)

Smoking Cessation | Tobacco Use Disorder | Mental Disorder

Spain
Moberg Pharma AB

Active, not recruiting

A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

Onychomycosis

United States, Canada
Atea Pharmaceuticals, Inc.

Terminated

Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model

Dengue

United States
North Carolina State University

Completed

Effects of Coffee Roasting on Blood Sugar Levels in Healthy Humans

Hyperglycemia

United States
AVEO Pharmaceuticals, Inc.

Completed

A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma

Carcinoma, Renal Cell

Ukraine, India, Russian Federation
Michael E. DeBakey VA Medical Center
Tuscaloosa Veterans Affairs Medical Center; Acorda Therapeutics; Ralph H. Johnson...

Withdrawn

Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)

Post Traumatic Stress Disorder (PTSD)

United States
Lund University
Region Skane

Completed

Diabetes Prevention - Immune Tolerance (DIAPREV-IT)

Type 1 Diabetes | Prediabetes

Sweden
Spaulding Rehabilitation Hospital
Robert Wood Johnson Foundation

Completed

Mother-Infant Intervention for Postpartum Depression and Associated Mother-Infant Relationship Dysfunction

Postpartum Depression

United States
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma

Respiratory Hypersensitivity

Germany
Merck Sharp & Dohme LLC

Completed

Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)

Type 2 Diabetes Mellitus (T2DM)
Aswan University Hospital

Completed

Oral Preoperative Carbohydrate on Early Postoperative Outcome After Cesarean Section

Cesarean Section Complications

Egypt
Hanlim Pharm. Co., Ltd.

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients

Acute Bronchitis

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Completed

A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy Volunteers

Osteoporosis
Rockefeller University
Icahn School of Medicine at Mount Sinai

Completed

Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitis

Atopic Dermatitis

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)

Hypercholesterolemia
Pfizer

Completed

First Safety Study in Humans of a Single Dose of CPG 52364

Healthy Volunteers

United States
Healthpoint

Completed

Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247

Venous Leg Ulcer (VLU)

Germany, Poland, Belgium, Hungary, Czechia
Merck Sharp & Dohme LLC

Completed

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Neoplasms, Glandular and Epithelial | Whooping Cough | Tetanus | Diphtheria | Meningitis
Merck Sharp & Dohme LLC

Completed

Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED)

Chemotherapy-Induced Nausea and Vomiting

3

Subscribe